Pierre ArsèneGRAIL Divestment: Perspectives, Valuation and its Potential Impact on the Liquid Biopsy Field (2/2)Returning from #JPM24, this post is a continuation from my previous post where I provided background on GRAIL’s situation and discussed its…11 min read·Jan 27, 2024----
Pierre ArsèneGRAIL Divestment: Perspectives, Valuation and its Potential Impact on the Liquid Biopsy Field (1/2)Holy Grail by DALL-E8 min read·Jan 4, 2024----
Pierre ArsèneAnalysing Exosome Biology Enables Breakthrough Diagnostic SolutionsFrom analysing exosome biology to developing nextgen liquid biopsy tests6 min read·Mar 25, 2022--1--1
Pierre ArsèneMy Prediction: Novel Exosome Technologies Are Going to Transform HealthcareA new hope to transform the standard of care5 min read·Jan 6, 2021--1--1